We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.72%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$868B
AUM Growth
-$6.92B
Cap. Flow
-$9.51B
Cap. Flow %
-1.1%
Top 10 Hldgs %
24.25%
Holding
14,094
New
1,864
Increased
4,890
Reduced
5,380
Closed
1,914

Sector Composition

Rank Sector Weight
1 Technology 1.7%
2 Consumer Discretionary 0.84%
3 Communication Services 0.67%
4 Financials 0.66%
5 Healthcare 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTD
13801
DELISTED
Vestand Inc
VSTD
-14,811
Closed -$23.8K
YRD
13802
CALL
Yiren Digital
YRD
$99.7M
-26,900
Closed -$160K
YRD
13803
PUT
Yiren Digital
YRD
$99.7M
-37,600
Closed -$223K
YSEP icon
13804
FT Vest International Equity Buffer ETF September
YSEP
$122M
-16,153
Closed -$412K
YSG
13805
PUT
Yatsen Holding
YSG
$281M
-13,200
Closed -$120K
ZDGE icon
13806
CALL
Zedge
ZDGE
$38M
-22,900
Closed -$66.6K
ZDGE icon
13807
PUT
Zedge
ZDGE
$38M
-12,600
Closed -$36.7K
ZH
13808
PUT
Zhihu
ZH
$275M
-151,800
Closed -$770K
ZIM icon
13809
ZIM Integrated Shipping Services
ZIM
$3.4B
-997,217
Closed -$16.7M
ZIMV
13810
CALL
DELISTED
ZimVie
ZIMV
-434,600
Closed -$8.23M
ZIMV
13811
PUT
DELISTED
ZimVie
ZIMV
-14,400
Closed -$273K
ZLAB icon
13812
CALL
Zai Lab
ZLAB
$2.92B
-113,900
Closed -$3.86M
ZNTL icon
13813
PUT
Zentalis Pharmaceuticals
ZNTL
$363M
-10,400
Closed -$15.7K
ZTO icon
13814
ZTO Express
ZTO
$16.2B
-57,445
Closed -$1.14M
ZYXI
13815
DELISTED
Zynex
ZYXI
-229,654
Closed -$333K
AVBP icon
13816
PUT
ArriVent BioPharma
AVBP
$1.44B
-33,000
Closed -$609K
BTSGU icon
13817
BrightSpring Health Services Unit
BTSGU
$1.55B
-5,000
Closed -$505K
NEUE
13818
DELISTED
NeueHealth
NEUE
-24,894
Closed -$166K
LFWD icon
13819
PUT
ReWalk Robotics
LFWD
$20.7M
-942
Closed -$8.02K
QQQI icon
13820
NEOS Nasdaq 100 High Income ETF
QQQI
$13.8B
-68,560
Closed -$3.73M
VTEC icon
13821
Vanguard California Tax-Exempt Bond ETF
VTEC
$3.08B
-7,487
Closed -$747K
AS icon
13822
Amer Sports
AS
$19B
-28,756
Closed -$987K
ARQ icon
13823
CALL
Arq
ARQ
$100M
-89,900
Closed -$644K
ARQ icon
13824
PUT
Arq
ARQ
$100M
-15,600
Closed -$112K
BRLSW icon
13825
Borealis Foods Inc Warrant
BRLSW
$1.06M
-39,449
Closed -$3.02K

Similar funds

Jeff Yass's Q4 2025 Portfolio in Review

As of Q4 2025, Jeff Yass held 14,094 positions worth $868B, down 0.79% from $875B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q4 2025 filing shows 1,864 new, 4,890 increased, 5,380 reduced and 1,914 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.08B.

By sector, the portfolio is most concentrated in Technology at 1.7% of assets, down from 1.7% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Jeff Yass's largest Q4 2025 buy was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M.
  • Jeff Yass added most to Invesco QQQ Trust in Q4 2025, an estimated $1.17B increase.
  • Jeff Yass's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.08B.
  • Jeff Yass fully exited Innovator US Equity Power Buffer ETF September in Q4 2025, selling an estimated $26.5M.
  • Jeff Yass's ten largest holdings make up 24% of its $868B portfolio in Q4 2025.
  • Jeff Yass opened 1,864 new positions and closed 1,914 in Q4 2025.
  • Jeff Yass's portfolio value fell 0.79% quarter-over-quarter to $868B.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.